Patients with high expression of atypical chemokine receptor 2 (ACKR2) may bind and internalize CCL2 for intracellular degradation to limit tumor metastasis, thus leading to low recruitment of CCR2+ monocytes along with high recruitment of CCR2+ NK cells93. The gene discussed is CCR2; the disease is neoplasm.